CMC Product Management Lead (Sr. Director)

Astellas

Northbrook (IL)

Hybrid

USD 180,000 - 240,000

Full time

5 days ago
Be an early applicant
Application generator

Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Hybrid work model
Remote work from anywhere in the US

Job summary

Astellas in Northbrook, IL seeks a seasoned CMC Asset Leader to drive end-to-end development, manufacturing, and lifecycle strategies for strategic assets. You will guide the asset’s VALUE through cross-functional teams and executive governance.

You will align regulatory, quality, supply chain, and commercial functions, translating complex technical needs into executable plans that maximize patient impact and portfolio VALUE.

Qualifications

  • Advanced degree in sciences, engineering, pharmaceutical sciences, or related field.
  • Significant experience leading global drug development programs or strategic assets.
  • Strong ability to influence senior leaders and governance bodies.

Responsibilities

  • Define and lead the integrated CMC asset strategy across development and launch.
  • Convert strategy into integrated, milestone-driven plans with budgets and risks.
  • Lead cross-functional VALUE teams spanning manufacturing, regulatory, quality, and supply chain.
  • Advise on asset lifecycle, investments, and external partnerships.

Skills

CMC leadership
Budget stewardship
Stakeholder management
Strategic leadership
Regulatory strategy
External partnerships
Executive communication

Education

PhD in sciences
MS in related field
BS with extensive experience

Job description

#26-POS00091506

Job Description

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Learn more at Astellas.com.

Are you driven to make a real difference in the lives of patients?

We're seeking passionate individuals who thrive in dynamic environments, embrace new ideas, and aren't afraid to take intelligent risks. People who act with unwavering integrity and are deeply committed to making a tangible impact.

Purpose and Scope:

This role works within a cross-functional Asset Maximization Team and is accountable for the CMC activities supporting the end-to-end advancement and VALUE maximization of one or more strategic assets from development candidate nomination through product registration, major product launch, and lifecycle transition. The CMC leader serves as the single, integrated voice for CMC product development, manufacturing and supply within the Asset Maximization Team, while also shaping asset strategy, driving alignment across assets and with enterprise goals, and ensuring high-quality execution across product research and development, manufacturing, regulatory, quality, supply chain, commercial, finance, and external partner workstreams. The role translates scientific, technical, operational, and business complexity into clear strategic options, risk-based recommendations, and executable plans that maximize patient impact, portfolio VALUE, and speed to decision.

Responsibilities and Accountabilities:

Strategy and Asset Leadership

  • Define, own and implement the integrated CMC asset strategy, ensuring alignment with target product profile, quality target product profile, clinical development plan, regulatory strategy, commercialization and launch plan, and lifecycle objectives.
  • Serve as the primary product development, manufacturing and supply representative on the asset maximization team, providing strategic input into asset plans, governance decisions, investment choices, and differentiating VALUE creation opportunities.
  • Holds accountability for the product strategy and product innovation ensuring alignment with the quality target product profile and lifecycle objectives
  • Accountable for managing and optimizing COGM to enhance product VALUE, profitability, and lifecycle sustainability
  • Translate complex scientific, technical, CMC regulatory, quality, manufacturing, supply chain, and commercial considerations into clear options, trade-offs, and implications for timelines, cost, quality, risk, and asset VALUE.

Integrated Execution and Delivery

  • Lead the cross-functional Product VALUE Team, integrating drug substance, drug product, analytical, CMC regulatory, quality, manufacturing, supply chain, finance, intellectual property and external partner workstreams.
  • Convert the integrated CMC asset strategy into fit-for-purpose integrated plans with clear milestones, dependencies, resource requirements, budget assumptions, risk mitigation pathways, and decision points.
  • Lead the manufacturing site selection ensuring alignment with the clinical development plan, commercialization and launch plans as well as with the PDM Supply Network Strategy.
  • Maintain clear end-to-end accountability for the overall control strategy including integrated CMC risk management of the asset across the patient axis in accordance with ICH Q8-Q11 principles and enterprise criteria
  • Drive delivery of phase-appropriate CMC development strategies consistent with Asset Maximization Team goals, regulatory expectations, launch readiness, and enterprise portfolio priorities.
  • Manage integrated CMC and asset-level budget and resource forecasts in partnership with functional leaders, ensuring disciplined prioritization and investment quality.

Regulatory, Quality, and Technical Integrity

  • Co-develop CMC regulatory strategy in close partnership with CMC regulatory, representing product development and CMC perspectives in health authority meetings and pre-submission interactions.
  • Ensure CMC activities, control strategy, submission content, product risk assessments, and regulatory filing roadmaps are scientifically robust, phase-appropriate, compliant, and aligned to quality expectations.
  • Maintain accountability for the quality, completeness, and strategic coherence of CMC submission content, including Module 3 and equivalent regional requirements.

Governance, Stakeholder Alignment, and Enterprise VALUE

  • Serve as the primary CMC interface to governance bodies, senior leaders, and alliance governance; present concise recommendations, decision options, risks, and implications for asset VALUE.
  • Drive alignment across functions, geographies, regions, and partners by eliminating silos, accelerating decision-making, and ensuring consistent execution against the integrated strategy.
  • Anticipate and resolve cross-functional risks and issues, escalating transparently through governance when decisions, resources, or trade-offs are required.
  • Represent the asset or program externally with alliance partners, CDMOs, vendors, regulators, key experts, and relevant stakeholder communities, ensuring credible, compliant, and consistent communication.

Capability Development

  • Contribute to developing enterprise capability by mentoring POD and VALUE team members, strengthening team effectiveness, and embedding high standards for execution, governance, quality, and VALUE creation and delivery.
  • Partner with functional leaders to support growth, development, and readiness of team members contributing to asset and product development outcomes.
Requirements

Required Qualifications:

  • Advanced degree in sciences, engineering, pharmaceutical sciences, or a related discipline; doctoral-level training preferred.
  • Minimum of 8 years of relevant experience with a PhD, 12 years with an MS, or 15 years with a BS, including significant experience leading complex, global, matrixed drug development programs or strategic assets.
  • Demonstrated success in product development, CMC leadership, enterprise program leadership, or asset leadership with accountability for strategy, execution, budget, governance, and cross-functional outcomes.
  • Broad understanding of the end-to-end development continuum, including CMC, technical development, clinical development, regulatory strategy, manufacturing, quality, supply chain, launch readiness, commercialization and LOE management.
  • Demonstrated strategic understanding of the competitive landscape, including competitor pipelines, market dynamics, and key differentiation opportunities.
  • Strong financial and business acumen, including experience with budget stewardship, investment decisions, resource prioritization, business case development, enhancing supply chain performance and resilience and VALUE optimization.
  • Demonstrates strong business development acumen, understands how to build and manage strategic alliances, and proactively applies industry benchmarking and competitive intelligence to shape asset, portfolio, and manufacturing strategies.
  • Track record of influencing senior leaders, governance bodies, investment forums, external partners, and health authorities in high-stakes, ambiguous environments.
  • Experience leading alliance relationships, outsourced networks, CDMOs, vendors, or other external partnerships in support of program execution.
  • Exceptional communication, synthesis, negotiation, stakeholder management, and team leadership skills.

Preferred Qualifications:

  • Experience leading assets from early development through regulatory approvals, launch, or post-approval lifecycle management.
  • Executive leadership and presence presenting in portfolio governance, investment committee, executive leadership, or board-adjacent decision forums.
  • Demonstrated ability to operate credibly across multiple therapeutic areas, modalities, or technical platforms.
  • Proven success building high-performing teams delivering outcomes and strengthening enterprise leadership capability.
  • Experience managing seamless transition from development to commercial operations, including product knowledge transfer, lifecycle planning, commercial supply readiness, and product discontinuation.
Location and Working Environment

This position is based in Northbrook, IL. Remote work from anywhere in the US is available.

At Astellas we recognize the importance of work/life balance, and we are proud to offer a hybrid working solution allowing time to connect with colleagues at the office with the flexibility to also work from home. We believe this will optimize the most productive work environment for all employees to succeed and deliver. Hybrid work from certain locations may be permitted in accordance with Astellas’ Responsible Flexibility Guidelines.

This position is a global role with strong

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Strategic CMC Lead, Cell Therapy (Sr. Director)
Strategic CMC Lead, Cell Therapy (Sr. Director)

Astellas • Westborough (MA)

Hybrid
USD 199,000 - 285,000
Medical Insurance
Dental Insurance
Vision Insurance
+5
Senior CMC & Asset Strategy Lead (Remote)
Senior CMC & Asset Strategy Lead (Remote)

Astellas • Northbrook (IL)

Hybrid
USD 180,000 - 240,000
Hybrid work model
Remote work from anywhere in the US
Pioneering Medicines: Executive Director, CMC (Chemistry, Manufacturing & Controls)
Pioneering Medicines: Executive Director, CMC (Chemistry, Manufacturing & Controls)

Flagship Pioneering • Cambridge (MA)

On-site
USD 228,000 - 313,500
Healthcare coverage
Annual incentive program
Retirement benefits
Pioneering Medicines: Executive Director, CMC (Chemistry, Manufacturing & Controls)
Pioneering Medicines: Executive Director, CMC (Chemistry, Manufacturing & Controls)

Flagship Pioneering • Boston (MA)

On-site
USD 228,000 - 314,000
Healthcare coverage
Annual incentive program
Retirement benefits
Lead, R&D Operational Planning (Manager/Senior Manager)
Lead, R&D Operational Planning (Manager/Senior Manager)

Astellas • Northbrook (IL)

Hybrid
USD 125,000 - 179,000
Medical, Dental, Vision Insurance
401(k) match
Annual bonus eligibility
+2
CMC Asset Lead, Associate Director
CMC Asset Lead, Associate Director

Biogen • Cambridge (MA)

Hybrid
USD 163,000 - 225,000
Medical Insurance
Dental Insurance
Vision Insurance
+4
Clinical Development Physician, Oncology Solid Tumor (Medical Director)
Clinical Development Physician, Oncology Solid Tumor (Medical Director)

Astellas • Northbrook (IL)

Hybrid
USD 207,000 - 296,000
Health insurance
401(k) match
Bonus program
+1
Associate Director, CMC Project Management
Associate Director, CMC Project Management

Enigma Search • South San Francisco (CA)

On-site
USD 180,000 - 240,000
CMC Asset Lead, Associate Director
CMC Asset Lead, Associate Director

Biogen, Inc. • Cambridge (MA)

Hybrid
USD 163,000 - 225,000
Medical, Dental, Vision, & Life ins.
Fitness & Wellness programs
Short- and Long-Term Disability
+5
Director, CMC Project Management
Director, CMC Project Management

Cullinanoncology • Cambridge (MA)

Hybrid
USD 200,000 - 260,000
Annual bonus
Equity awards
Medical, dental, vision insurance
+3